ATG5 and breast carcinoma: Interestingly, similar results were obtained in the RAS mutant breast cancer cell line MDA-MB-231, pointing to an oncogenic function of ATG5/7 or the autophagic pathway in RAS-driven breast cancer cells, as it has been proposed for other cancer types [72].